Confluence of Biological Researches for Cure and Therapeutic
Journal of Biology and Medical-Research has announced almost 50 percent discount on article processing charge to commemorate its Anniversary. On behalf of the Journal of Biology and Medical-Research, as Editor-in-Chief, it is my distinct honour and privilege to inform you that, it’s been years we have started the Journal, now we are celebrating the Anniversary and we are privileged to welcome Analytical Society to our journal. As Editor-In-Chief it is my great pleasure and honour to welcome you to the Journal of Biology and Medical-Research. (iMedPuB) publication.
In modern age large section of human society is living in polluted surroundings and facing ill effects of environmental stress and high morbidity due to presence of disease pathogens and pollutants in his surroundings. Global climate change is imposing three long range effects lethality, post disease morbidity and rising resistance in pathogens against drugs/antibiotics. After seeing rising trends of disease transmission, morbidity and lack of quick diagnosis, and availability of appropriate drug regimens and methods of drug delivery, severity of infection, lethality and morbidity rate has been increased. There is need to develop new methods, technologies, low toxic and safer formulations to combat insect vectors on one hand, and diagnosis of mutation in disease strains on another. To find solutions of drug and pesticide resistance novel bioorganic compounds from plant origin are to be used for making broad spectrum nano-herbal drug formulations and complexes of green chemicals be used to fight against drug resistance and insecticides resistance.
There is another area which can assist in disease therapeutics mainly cancer. There are several toxins/proteins and peptides have been isolated from animal venoms which show novel cytotoxicity to cancer cells and potentially inhibit growth of microbes. Venom toxin short peptides and their analogues can be used to design a new generation of specific inhibitor of human angiogenesis. These can also inhibit progression of cancer and affect cyclin function. T cell proteome for wasp venom can facilitate the future development of T cell-based immunotherapeutic approaches. Development of drug delivery systems can be made by using toxin components to prepare Nano scale therapeutic devices to target brain tumors, breast, colorectal cancer and oral cancers.
The Journal is successfully running in the which covers a wide variety of specialties including Cell Biology and Toxicology, Oncology Microbiology, Biotechnology & reaching out to analytical scientists worldwide. The Journal emphasizes high-level research and education. Original research articles, reviews, short communications, and letters to the editors in the fields of biology and medical research and separation are welcome.
All the manuscripts are subjected to vigorous peer review process to ensure quality and originality. In addition to research articles, the journal also publishes high quality commentaries reviews and perspectives aimed at encapsulating the latest knowledge that synthesizes new theories and advancement in the field of biological sciences. Submit manuscript at http://www.imedpub.com/submissions/biology-medical-research.html Or mail to this mail id firstname.lastname@example.org
Editorial Assistant Journal of Biology and Medical Research.
E-mail id: email@example.com